Dogwood Therapeutics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Net Income | -2,280 | -1,049 | -1,291 | -1,103 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -910 | -811 | -937 | -1,469 |
Cash | 2,039 | 3,020 | 2,379 | 3,316 |
Basic Shares | 1,110 | 1,110 | 770 | 770 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Net Income | -5,296 | -12,247 | -15,960 | -10,346 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -4,870 | -11,467 | -15,689 | -3,895 |
Cash | 3,316 | 7,030 | 14,008 | 29,795 |
Basic Shares | 770 | 733 | 333 | 332 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$1.14 |
2024-03-31 | -$1.67 |
2023-12-31 | -$1.43 |
2023-09-30 | -$1.61 |
